Rockhampton Hospital is the largest major hospital in Central Queensland, Australia. Operated by Queensland Health as a public hospital, the hospital offers a wide range of medical services to a population of about 230,000 throughout the Rockhampton, Gladstone, the Capricorn Coast and Emerald communities.

There are 300 beds in Rockhampton Hospital.

During the past decade, Rockhampton Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rockhampton Hospital" #1 sponsor was "Australian and New Zealand Intensive Care Research Centre" with 1 trials, followed by "Gold Coast Hospital and Health Service" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Loxo Oncology, Inc." with 1 trials sponsored and "UMC Utrecht" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rockhampton Hospital" #1 collaborator was "Intensive Care National Audit & Research Centre" with 2 trials as a collaborator, "Medical Research Institute of New Zealand" with 2 trials as a collaborator, "ANZICS Clinical Trials Group" with 1 trials as a collaborator, "Australian Red Cross" with 1 trials as a collaborator and "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Rockhampton Hospital" are "Carcinoma, Non-Small-Cell Lung" (1 trials), "Coagulopathy" (1 trials), "Colorectal Neoplasms" (1 trials), "Community-acquired Pneumonia, Influenza, COVID-19" (1 trials) and "Critically Ill, Mechanically Ventilated" (1 trials). Many other conditions were trialed in "Rockhampton Hospital" in a lesser frequency.

Most popular intervention types in "Rockhampton Hospital" are "Drug" (4 trials), "Behavioral" (1 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "5-Fluouracil" (1 trials), "ARB + DMX-200" (1 trials), "Amoxicillin-clavulanate" (1 trials) and "Anakinra" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rockhampton Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Rockhampton Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Rockhampton Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rockhampton Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".